Detail akcie Pharmena online

Business Summary: Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Pharmena SA revenues remained flat at PLN299K. Net income before extraordinary items totaled PLN27M vs. loss of PLN5.1M. Revenues reflect Egypt segment increase of 88% to PLN197K, United Kingdom segment increase of 16% to PLN256K, also reflect Hair Care segment decrease of 50% to PLN7.4M, Face Care segment decrease of 45% to PLN1M, Poland segment decrease of 51% to PLN8.4M.